<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01511835</url>
  </required_header>
  <id_info>
    <org_study_id>MyoIN_diab</org_study_id>
    <nct_id>NCT01511835</nct_id>
  </id_info>
  <brief_title>Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGUNCO Obstetrics and Gynecology Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AGUNCO Obstetrics and Gynecology Centre</source>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the efficacy of myo-inositol in preventing gestational
      diabetes in high risk pregnant women.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>OGTT</measure>
    <description>The diagnostic 75g oral glucose tolerance test (OGTT) is performed between 24 and 28 weeks of gestation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of pregnant women with gestational diabetes</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of pregnant women requiring insulin treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight gain at the end of pregnancy</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of newborn infants whose weight is more than 4000 g</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of newborn infants requiring Neonatal Intensive Care (NIC)</measure>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Myo-inositol powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Myo-inositol soft gel capsules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Folic acid</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>inositol + folic acid</intervention_name>
    <description>2000 mg of inositol+200mcg of folic acid; 2 per diem</description>
    <arm_group_label>Myo-inositol powder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>inositol + folic acid</intervention_name>
    <description>600 mg of inositol + 200mcg of folic acid; 2 cp per diem</description>
    <arm_group_label>Myo-inositol soft gel capsules</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Folic Acid</intervention_name>
    <description>Folic Acid 400mcg; 1 cp/die</description>
    <arm_group_label>Folic acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        60 women in their first trimester of pregnancy affected by one or more of the following
        risk factors:

          -  Glycemia levels &gt; 92 mg/dl

          -  BMI &gt; 30

          -  At least a parent or a brother (or sister)affected by diabetes

          -  Pre-existing pregnancy with gestational diabetes

        Exclusion Criteria:

          -  Pregnant women affected by pregestational diabetes

          -  Twin pregnancy

          -  Patients affected by pre-existing diseases in pregnancy (diabetes excluded)

          -  Patients affected by chronic disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Vittorio Unfer</last_name>
    <email>vunfer@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gianfranco Carlomagno</last_name>
    <email>gianfranco.carlomagno@agunco.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AGUNCO</name>
      <address>
        <city>Rome</city>
        <zip>00155</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianfranco Carlomagno</last_name>
      <email>gianfranco.carlomagno@agunco.it</email>
    </contact>
    <investigator>
      <last_name>Vittorio Unfer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gianfranco Carlomagno</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Papaleo E, Unfer V, Baillargeon JP, Chiu TT. Contribution of myo-inositol to reproduction. Eur J Obstet Gynecol Reprod Biol. 2009 Dec;147(2):120-3. doi: 10.1016/j.ejogrb.2009.09.008. Epub 2009 Oct 2. Review.</citation>
    <PMID>19800728</PMID>
  </reference>
  <reference>
    <citation>Corrado F, D'Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, Di Benedetto A. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011 Aug;28(8):972-5. doi: 10.1111/j.1464-5491.2011.03284.x.</citation>
    <PMID>21414183</PMID>
  </reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2011</study_first_submitted>
  <study_first_submitted_qc>January 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2012</study_first_posted>
  <last_update_submitted>January 13, 2012</last_update_submitted>
  <last_update_submitted_qc>January 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>pregnancy</keyword>
  <keyword>myo-inositol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Inositol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

